Model
Edge
CytomX Therapeutics Inc.
0001601583
Filing Type
4
Filing Date
5/16/2024
Updated
5/17/24, 3:36 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership